Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has a diverse ownership structure, with retail investors holding the majority stake at 54%, followed by institutions at 35%. Hedge funds and insiders also have significant ownership. Analyst sentiments and insider ownership indicate potential future trends in the company's performance.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing